4539.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 09:15):

Nippon Chemiphar Co., Ltd., together with its subsidiaries, manufactures, markets, imports, exports, and sells, ethical pharmaceuticals and diagnostic agents in Japan and internationally...

Stats
Dzisiejszy wolumen	1 500.00
Średni wolumen	4 326.00
Kapitalizacja rynkowa	5.86B
EPS	¥0 ( 2024-01-30 )
Następna data zysków	( ¥0 ) 2024-05-09
Last Dividend	¥50.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-24.35
ATR14	¥0 (0.00%)

Nippon Chemiphar Co., Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nippon Chemiphar Co., Finanse

Annual	2022
Przychody:	¥31.56B
Zysk brutto:	¥8.19B (25.94 %)
EPS:	¥93.92

FY	2022
Przychody:	¥31.56B
Zysk brutto:	¥8.19B (25.94 %)
EPS:	¥93.92

FY	2022
Przychody:	¥32.51B
Zysk brutto:	¥9.07B (27.91 %)
EPS:	¥194.33

FY	2021
Przychody:	¥31.54B
Zysk brutto:	¥11.44B (36.28 %)
EPS:	¥137.75

Financial Reports:

No articles found.

Nippon Chemiphar Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥50.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nippon Chemiphar Co., Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.79 - average (59.94%) | Divividend Growth Potential Score: 1.529 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥30.00	2008-03-26
Last Dividend	¥50.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	¥1 040.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.76	--
Div. Sustainability Score	5.79
Div.Growth Potential Score	1.529
Div. Directional Score	3.66	--

Next Divdend (Est)
(2025-03-19)

¥0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.76

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8025.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7272.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
6507.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
5727.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4538.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3738.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3023.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
1888.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
9873.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8920.T	Ex Dividend Junior	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.00787	1.500	-0.157	-0.236	[0 - 0.5]
returnOnAssetsTTM	-0.00473	1.200	-0.158	-0.189	[0 - 0.3]
returnOnEquityTTM	-0.0130	1.500	-1.255	-1.883	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.43	0.800	2.86	2.29	[1 - 3]
quickRatioTTM	1.563	0.800	5.51	4.41	[0.8 - 2.5]
cashRatioTTM	0.747	1.500	6.96	10.00	[0.2 - 2]
debtRatioTTM	0.344	-1.500	4.27	-6.41	[0 - 0.6]
interestCoverageTTM	-3.58	1.000	-2.44	-2.44	[3 - 30]
operatingCashFlowPerShareTTM	796.41	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	796.41	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.934	-1.500	6.26	-9.40	[0 - 2.5]
grossProfitMarginTTM	0.251	1.000	9.15	9.15	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0153	1.000	-2.31	-2.31	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.164	1.000	-0.199	-0.199	[0.2 - 2]
assetTurnoverTTM	0.601	0.800	9.33	7.46	[0.5 - 2]
Total Score				5.79

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-24.11	1.000	-2.54	0	[1 - 100]
returnOnEquityTTM	-0.0130	2.50	-0.807	-1.883	[0.1 - 1.5]
freeCashFlowPerShareTTM	796.41	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.11	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	796.41	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.589	1.500	-7.26	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0939	1.000	-0.153	0	[0.1 - 0.5]
Total Score				1.529

Nippon Chemiphar Co.,

Nippon Chemiphar Co., Ltd., together with its subsidiaries, manufactures, markets, imports, exports, and sells, ethical pharmaceuticals and diagnostic agents in Japan and internationally. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. The company also develops NC-2400, a PPAR-delta agonist; NC-2500, a novel advanced xanthine oxidoreductase inhibitor for the treatment of hyperuricemia/gout; and NC-2600, a P2X4 receptor antagonist for the treatment of neuropathic pain. In addition, it develops NC-2700, a novel urate transporter 1 inhibitor that enhance excretion urate to urine; NC-2800, a delta opioid receptor agonist for the treatment of depression/anxiety; Uralyt-U, an alkalization therapeutic drug; Soleton, an analgesic and anti-inflammatory drug; and Calvan, a hypertension therapeutic drug. Further, the company provides quasi-drugs, nutrients, health foods, cosmetics, and various type of creams. It distributes its generic pharmaceuticals through wholesalers to hospitals and pharmacies. The company was formerly known as Hitachi Chemical Co., Ltd. and changed its name to Nippon Chemiphar Co., Ltd. in 1970. Nippon Chemiphar Co., Ltd. was founded in 1950 and is headquartered in Tokyo, Japan.

Aktualne aktualizacje dla Nippon Chemiphar Co., [4539.T]

Upcoming Earnings Alert

Nippon Chemiphar Co., Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for JPX

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)